Dis-Chem Pharmacies (JSE:DCP) 3-Year EBITDA Growth Rate : 14.70% (As of Aug. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Dis-Chem Pharmacies 3-Year EBITDA Growth Rate?

Dis-Chem Pharmacies's EBITDA per Share for the six months ended in Aug. 2023 was R1.07.

During the past 12 months, Dis-Chem Pharmacies's average EBITDA Per Share Growth Rate was -6.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 14.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Dis-Chem Pharmacies was 22.70% per year. The lowest was 8.40% per year. And the median was 14.70% per year.

Competitive Comparison of Dis-Chem Pharmacies's 3-Year EBITDA Growth Rate

For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dis-Chem Pharmacies's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Dis-Chem Pharmacies's 3-Year EBITDA Growth Rate falls into.

Dis-Chem Pharmacies 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Dis-Chem Pharmacies (JSE:DCP) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Dis-Chem Pharmacies 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Dis-Chem Pharmacies's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Dis-Chem Pharmacies (JSE:DCP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dis-Chem Pharmacies Ltd (JSE:DCP) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685

Website

https://www.dischem.co.za

Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries its business operations principally in South Africa.